Market Update: 12-18-20

The Issachar Fund (LIONX, BRI & ESG) is 65% invested in 43 growth stocks on Thursday, December 17, 2020.  After last week’s round of profit-taking, I purchased new growth stocks, and I plan to get more invested shortly.  Many stocks are extended in price, and P/E ratios are expanding, but I believe there is still room to run...

Market Update: 12-14-20

The Issachar Fund (LIONX, BRI & ESG) is 20% invested in 20 growth stocks on Sunday, December 13, 2020.  The S&P 500 Index hit an all-time high last Tuesday and slid lower into Friday as rumors of a stimulus compromise diminished.  I believe stocks are extended in price, and P/E ratios are expanding in anticipation of a stimulus...

Market Update: 12-07-20

The Issachar Fund (LIONX, BRI & ESG) is 100% invested in 52 growth stocks on Sunday, December 6, 2020.  The top three sector LIONX weightings are Software, Medical, and Chips.  I am still bullish on the stock market, and I expect the rally to continue melting higher into Christmas.  However, I am not finding fresh setups to buy...

Market Update: 11-30-20

Growth Leads the Charge!     Market Looks Healthy!     The Issachar Fund (LIONX, BRI & ESG) is 100% invested in 54 growth stocks on Sunday, November 29, 2020.  My conviction level increased last week because stocks did what I expected, so I took LIONX to a fully invested position.  If new money came into LIONX today, I...

Market Update: 11-23-20

Fed Steps on the Gas!     Looking Good!   The Issachar Fund (LIONX, BRI & ESG) is 85% invested in 45 growth stocks on Sunday, November 22, 2020.  I like how select growth stocks have been basing (going sideways) and appear to be under accumulation, so I purchased more stocks and added to existing ones.  I am finding...

Market Update: 11-16-20

The Issachar Fund (LIONX, BRI & ESG) is 65% invested in 33 growth stocks on Sunday, November 15, 2020.  I did some buying and selling last week, trying to stay in sync with the stock leadership changes I see in the market.  There appears to be some rotation out of recent leading “stay at home” growth stocks into value...